SEC Form 4 · accession 0001209191-16-101094
CRAY INC · CRAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian C Henry
Officer — Executive VP & CFO
Period of report
Feb 18, 2016
Accepted (ET)
Feb 22, 2016 · 6:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000949158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 18, 2016 | S | 1,334 | $40.9393 | D | 103,648 | D | |
| Common StockF3 | Feb 18, 2016 | S | 26,900 | $41.9319 | D | 76,748 | D | |
| Common Stock | Feb 19, 2016 | M | 348 | $6.63 | A | 77,096 | D | |
| Common Stock | Feb 19, 2016 | M | 55,000 | $6.08 | A | 132,096 | D | |
| Common Stock | Feb 19, 2016 | S | 348 | $41.53 | D | 131,748 | D | |
| Common StockF4 | Feb 19, 2016 | S | 25,605 | $40.68 | D | 106,143 | D | |
| Common StockF5 | Feb 19, 2016 | S | 29,395 | $41.4553 | D | 76,748 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F6 | $6.63 | Feb 19, 2016 | M | 348 | D | — | May 16, 2018 | Common Stock | 348 | 0 | D |
| Stock Option (right to buy)F7 | $6.08 | Feb 19, 2016 | M | 55,000 | D | — | Nov 16, 2021 | Common Stock | 55,000 | 0 | D |
Explanation of responses
- F1The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- F2The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.36 to $41.32 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- F3The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.36 to $42.23 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
- F4The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.09 to $41.08 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
- F5The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.09 to $41.91 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5).
- F6The option was 100% vested and exercisable on May 16, 2012.
- F7The option was 100% vested and exercisable on August 3, 2015.